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Many Roads Must a Man Walk Down?Tiago Bilhim, MD, PhD, EBIR, FCIRSE, FSIRThe study by de Assis et al titled “Angiographic Findings
during Repeat Prostate Artery Embolization” (1) highlights
2 unanswered questions that have been pending since
prostatic artery embolization (PAE) arose as an alternate
treatment option for patients with benign prostatic hyper-
plasia (BPH) and lower urinary tract symptoms (LUTS).
First, how many independent prostatic arteries (PAs) do we
have (and how should we call them)? Second, should we
embolize all arteries going into the prostate? If we did not
know the answers before reading this manuscript, we will
still probably not be able to answer them afterward. How-
ever, this study raises the potential role of additional PAs
that are left nonembolized during PAE. The authors hy-
pothesize that these arteries may be a reason for prostatic
revascularization responsible for symptomatic relapse
needing reintervention. A retrospective analysis of 10 pa-
tients who underwent repeated PAE 2–8 years after the first
embolization is presented. All patients responded with
symptomatic relief after the first PAE. However, relapsing
LUTS prompted reintervention and repeated PAE was per-
formed. During repeated PAE, almost 60% of pelvic sides
had more than 1 PA feeding the prostate, whereas in the
remainder 40% of pelvic sides only 1 PAwas identified. The
authors report 2 independent PAs feeding the prostate in
30% of pelvic sides during the first PAE, with 1 PA left
nonembolized. This 30% rate of independent PAs is strik-
ingly different from the previously reported 8% rate from
the same group in a larger cohort of 143 patients (2). One
could probably argue that this is due to selection bias,
meaning that this is a subgroup of patients who previously
underwent PAE and were “prone” to have more than 1 in-
dependent PA feeding the prostate. The sample size of 10
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j.jvir.2019.01.026If we look into anatomy studies with cadavers, the re-
ported rates of independent PAs feeding the prostate ranges
from 0 (3), to 30% (4) and even 100% (5,6). When using
computerized tomographic (CT) angiography (CTA) and
digital subtraction angiography (DSA) to study the anatomy
of the PAs, the reported rate of independent PAs is 40% (7).
With the use of intraprocedural cone-beam CT (CBCT) and
digital subtraction angiography, the reported rate of inde-
pendent PAs ranges from 7% (8) to 20% (9). With such a
huge variability in the reported rates of independent PAs,
even when using the same technical approach (eg, cadavers,
CTAþDSA, DSA alone, and DSAþCBCT) or within the
same cohort (1,2), it seems obvious that something is elusive.
Where is the truth? It depends on what you consider to be
true or false, but usually it is somewhere in between ex-
tremes. There is more here than meets the eye; and probably
these discrepancies depend on how hard you look for these
arteries and how you name them. How should we call these
arteries? The names of anterior-lateral and posterior-lateral
PAs have been proposed based on the penetration of these
branches in the prostatic capsule (7,10). The “main” PA for
patients with BPH would naturally be the artery feeding the
central gland. This artery has been found to penetrate the
prostatic capsule in the anterior-lateral quadrants, so it is
called the anterior-lateral (AL-PA) or central-gland PA. The
artery feeding most of the peripheral zone of the prostate and
prostate apex was found to penetrate the prostatic capsule in
the posterior-lateral quadrants, so it is called the posterior-
lateral (PL-PA) or peripheral-gland PA (1,5,7,10).
In the study by Assis et al (1) the PL-PA was present and
independent from the AL-PA in 30% of pelvic sides during
the first PAE and was held to be the main “culprit” for the
prostatic revascularization in 21% of pelvic sides. Naturally,
all nonembolized PL-PAs during the first PAE had vascu-
larization to the prostate. But was this vascularization any
different from the first PAE compared with the repeated
PAE? Should these arteries have been embolized during the
first procedure? One is left to wonder. The authors compared
patients who underwent PL-PA embolization with those
who did not during the first PAE and found that embolizing
the PL-PA during the first PAE reduced the risk of revas-
cularization through that artery. But what about other ar-
teries feeding the prostate? The authors also showed that the
distal segments of the obturator, superior vesical, and penile
arteries were responsible for prostatic revascularization in
63% of pelvic sides. Should these arteries have been
embolized in the first PAE? Were they even present at that
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been reported as collateral routes in patients with PA oc-
clusion due to atherosclerosis (11). Naturally, they can also
develop after nonatherosclerotic iatrogenic occlusions of the
PAs. Most importantly, the AL-PA was also found to be the
major PA responsible for prostatic revascularization in 42%
of pelvis sides, leaving us wondering about the presumed
“permanent” nature of the embolic materials we are using. If
we put all the mathematics together (with or without the
help of our friend the calculator), one could argue that AL-
PA revascularization and the collaterals arising from the
distal segments of the internal iliac branches accounted for
virtually all prostatic revascularizations, questioning the
added value of PL-PA embolization during PAE.
Assis et al imply that independent PL-PAs should be
looked for and embolized during PAE (1). We should
probably be cautious about advising to “seek and destroy”
all potential PAs identified in the pelvis, because this
approach may lead to more radiation exposure to patients
and interventional radiologists with the potential to increase
nontarget embolization. PAE is already a “feared” and
“complicated” procedure owing to the complex anatomy of
the pelvic vessels, with reported severe adverse events due
to high radiation exposure and nontarget embolization
(12,13). There are no doubts that repeated PAE makes this
procedure even more complex with a higher rate of inde-
pendent PAs feeding the prostate. Assis et al embolized 31
PAs in 10 patients (1) but, unfortunately, provide no data on
fluoroscopy and procedural times, air kerma, or dose-area-
product. So maybe instead of making a complex proced-
ure even harder, we could look into ways of reducing the
revascularization of the AL-PAs. Should we look into more
“permanent” embolics? Naturally, we can not prevent col-
laterals from the distal segments of the internal iliac artery to
develop after a successful PAE, but we can try to prevent
revascularization of the embolized PAs. Preliminary data on
PAE with liquid agents (ethylene vinyl alcohol copolymer)
showed disappointing results (14). Placing coils in the AL-
PA or gelfoam after embolization with particles is another
option. But, as with uterine artery embolization, this is
probably not a very good idea. Instead of preventing AL-PA
revascularization, we are just making our lives miserable in
the near future: closing an “easy” entrance door to the
prostate to stimulate the development of collateral and
tortuous “difficult” new doors. Maybe AL-PA revasculari-
zation or even PL-PA revascularization is “good news”
when dealing with repeated PAE, because these arteries are
probably easier to selectively catheterize. We are left with
many unanswered questions, as always.I am not sure about the suggestion of embolizing all
potential feeders to the prostate during PAE. It has been
shown recently in a retrospective analysis that embolizing 3
or more PAs did not lead to better clinical outcomes than
embolizing 2 PAs, 1 on each pelvic side (15). I also doubt
that the answers will be “blowin’ in the wind.” Should we
follow all roads that lead into the prostate to perform PAE
more effectively? One can only hope for future studies to
tell, but interventional radiologists have been doing PAE
quite well for the last decade.REFERENCES
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